CatSci Ltd logo — Excellence in Medicines Development

CatSci Ltd

Excellence in Medicines Development

Founded 2010 United Kingdom United Kingdom 100 employees Growth Total: $180.00K Biopharma, Biotechnology +3

General Information

Company Name CatSci Ltd
Founded Year 2010
Location United Kingdom United Kingdom
Employees 100
Industries Biopharma, Biotechnology, Life Sciences +2
Funding Stage Growth
Business Model B2B
Revenue Model Service Fee, Project Based, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with CatSci Ltd. To contact CatSci Ltd, visit catsci.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CatSci Ltd compare?

A PDF of CatSci Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CatSci Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CatSci Ltd

CatSci Ltd, founded in 2010, is an award-winning innovation partner in the Biopharma, Biotechnology, Life Sciences, Manufacturing, and Pharmaceutical industries. Known for its excellence in medicines development, the company breaks down silos in small molecules, TACS, glues, and oligonucleotides CMC development. This allows them to accelerate the delivery of life-changing medicines from candidate selection to product launch and beyond.

Operating out of the United Kingdom, CatSci Ltd offers tailored services including route scouting, initial scale-up, and comprehensive process optimization for clinical and commercial manufacturing. A notable partnership with AGC Pharma Chemicals enhances their capability in scalable small molecule API manufacturing.

Recognized for Innovative Growth and ESG Excellence in numerous awards, their last investment was a £180.00K grant in early 2025 from UK Research and Innovation. With a technically adept team and advanced facilities, CatSci Ltd stands poised for further impact in the evolving healthcare sector.

Business keywords: Medicines Development, Small Molecules, Oligonucleotides, CMC Development, Route Scouting, Scale-up, Process Design, Tech Transfer, Catalysis, Material Science, GMP Analytical Services, HPAPI Development, Green Chemistry, Custom Synthesis

Services & Products

End-to-end drug development
Preclinical to post-approval support
Process Development
Analytical Control
Technology Transfer

Target Customers

Biotechnology Companies Pharmaceutical Companies Contract Research Organizations (CROs) Contract Development and Manufacturing Organizations (CDMOs)

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant £180.00K 1
UK Research and Innovation
01 Feb 2025
Growth Equity VC Undisclosed 1
Keensight Capital
01 Jun 2022

CatSci Ltd Alternatives & Competitors

View All Alternatives
CatSci Ltd vs
AcceleDev
AcceleDev United States

Leading CDMO with small molecule synthetic chemistry R&D, process development & commercial scale pro...

15 employees
Manufacturing, Pharmaceutical
CatSci Ltd vs

Research for tomorrow

4 employees
Manufacturing, Pharmaceutical
CatSci Ltd vs
Wheeler Bio, Inc.
Wheeler Bio, Inc. United States

CMC Made for Biotechs

Series A
76 employees
Biotechnology, Health and Wellness

FAQ About CatSci Ltd

Excellence in Medicines Development
CatSci Ltd was founded in 2010.
CatSci Ltd is headquartered in United Kingdom.
CatSci Ltd operates in Biopharma, Biotechnology, Life Sciences, Manufacturing and Pharmaceutical. Its work centres on Medicines Development, Small Molecules, Oligonucleotides and CMC Development. Its customers include Biotechnology Companies, Pharmaceutical Companies and Contract Research Organizations (CROs).
CatSci Ltd has a B2B business model. Its revenue comes from Service Fee, Project Based and Consulting Fee.
CatSci Ltd has approximately 100 employees.
CatSci Ltd has completed 2 funding rounds, raising a total of $180.00K. The latest funding stage is Growth.
CatSci Ltd offers: End-to-end drug development, Preclinical to post-approval support, Process Development, Analytical Control, Technology Transfer.
Top alternatives and competitors to CatSci Ltd include AcceleDev, Rane Pharmaceutical Inc, Wheeler Bio, Inc., Kymos Group, Cambridge Major Laboratories, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CatSci Ltd and AcceleDev are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CatSci Ltd, https://bouncewatch.com/company/catsci-ltd, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes